10/07/2021 Boston Globe: Neumora hopes to bring precision medicine to brain disease treatments Read More
10/07/2021 Boston Business Journal: Psychiatric drug startup launches with $500M, Amgen partnership Read More
10/07/2021 Chemical & Engineering News: Neumora launches with $500 million to develop drugs for brain diseases Read More
10/07/2021 FierceBiotech: Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D Read More